0 followers
Dyadic International, Inc. (OTCQX: DYAI) is a global biotechnology company focused on further improving and leveraging the patented and proprietary C1 expression system to help bring biologic vaccines and drugs to market faster, in greater volumes, at lower cost, and with new properties to drug dev... Read more
Mark A. Emalfarb